Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment

Approximately 90 % of patients who die of prostate cancer (PCa) have bone metastases, often promoting osteoblastic lesions. We observed that 88 % of castration-resistant PCa (CRPC) bone metastases express prostatic acid phosphatase (PAP), a soluble secreted protein expressed by prostate epithelial c...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Larson, Sandy R., Chin, Jessica, Zhang, Xiaotun, Brown, Lisha G., Coleman, Ilsa M., Lakely, Bryce, Tenniswood, Martin, Corey, Eva, Nelson, Peter S., Vessella, Robert L., Morrissey, Colm
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3946934/
https://ncbi.nlm.nih.gov/pubmed/24242705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10585-013-9625-2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg